These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3384359)

  • 61. Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension.
    Bihari D; Westaby D; Gimson A; Crossley I; Harry J; Williams R
    Br J Clin Pharmacol; 1984 Jun; 17(6):753-7. PubMed ID: 6146330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Comparative study of propranolol versus propranolol plus isosorbide 5-mononitrate in portal hypertension in cirrhotics. Evaluating splanchnic hemodynamics with color Doppler ultrasound].
    Sánchez del Monte J; Ramos Gómez MV; Velazquez Ochoa E
    Rev Gastroenterol Mex; 2005; 70(3):261-8. PubMed ID: 17063781
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
    Westaby D; Gimson A; Hayes PC; Williams R
    Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
    Merkel C; Sacerdoti D; Bolognesi M; Buonamico P; Sticca A; Amodio P; Angeli P; Micotti L; Gatta A
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1221-5. PubMed ID: 10563530
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of intraportal nitroglycerin on portosystemic hemodynamics in patients with cirrhosis: comparison with i.v. route.
    Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
    J Clin Gastroenterol; 1991 Aug; 13(4):424-31. PubMed ID: 1918848
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A; Calès P; Lebrec D
    Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis.
    Sarin SK; Sethi KK; Nanda R
    Gut; 1987 Mar; 28(3):260-6. PubMed ID: 3570030
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
    Jones AL; Bangash IH; Walker J; Simpson KJ; Finlayson ND; Hayes PC
    Gut; 1995 Jan; 36(1):104-9. PubMed ID: 7890211
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis.
    Fukuda T; Narahara Y; Kanazawa H; Matsushita Y; Kidokoro H; Itokawa N; Kondo C; Atsukawa M; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2014 Feb; 29(2):325-9. PubMed ID: 24033356
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.
    Merkel C; Gatta A; Bolognesi M; Padrini R; Finucci GF; Angeli P; Ruol A
    Br J Clin Pharmacol; 1988 Sep; 26(3):273-7. PubMed ID: 3179167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New approaches in the pharmacologic treatment of portal hypertension.
    Bosch J; García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Rodés J
    J Hepatol; 1993; 17 Suppl 2():S41-5. PubMed ID: 8098342
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Am J Physiol; 1983 Jan; 244(1):G52-7. PubMed ID: 6849394
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comparison of the haemodynamic effect of isosorbide-5-mononitrate and isosorbide dinitrate administered in intravenous injection to patients with acute myocardial infarction.
    Daskalov TR
    Cor Vasa; 1989; 31(5):376-86. PubMed ID: 2612170
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
    Albillos A; Lledó JL; Bañares R; Rossi I; Iborra J; Calleja JL; Garrido A; Escartin P; Bosch J
    Hepatology; 1994 Sep; 20(3):611-7. PubMed ID: 7915703
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Postprandial changes in portal haemodynamics in patients with cirrhosis.
    O'Brien S; Keogan M; Patchett S; McCormick PA; Afdhal N; Hegarty JE
    Gut; 1992 Mar; 33(3):364-7. PubMed ID: 1568656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis.
    Pringle SD; McKee RF; Garden OJ; Lorimer AR; Carter DC
    Aliment Pharmacol Ther; 1988 Oct; 2(5):451-9. PubMed ID: 2979267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.